Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells

about

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells

Item

http://www.wikidata.org/entity/Q57816977

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 09 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Olmutinib (BI1482694/HM61713), ...... rug Resistance in Cancer Cells

@en

Olmutinib (BI1482694/HM61713), ...... rug Resistance in Cancer Cells

@nl

type

Item

label

Olmutinib (BI1482694/HM61713), ...... rug Resistance in Cancer Cells

@en

Olmutinib (BI1482694/HM61713), ...... rug Resistance in Cancer Cells

@nl

prefLabel

Olmutinib (BI1482694/HM61713), ...... rug Resistance in Cancer Cells

@en

Olmutinib (BI1482694/HM61713), ...... rug Resistance in Cancer Cells

@nl

P1476

Olmutinib (BI1482694/HM61713), ...... rug Resistance in Cancer Cells

@en

P2093

Chao-Yun Cai

http://www.w3.org/2001/XMLSchema#string

Leli Zeng

http://www.w3.org/2001/XMLSchema#string

Pranav Gupta

http://www.w3.org/2001/XMLSchema#string

Qiu-Xu Teng

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

Ying-Fang Fan

http://www.w3.org/2001/XMLSchema#string

Zhe-Sheng Chen

http://www.w3.org/2001/XMLSchema#string

Zi-Ning Lei

http://www.w3.org/2001/XMLSchema#string

P2860

A multidrug resistance transporter from human MCF-7 breast cancer cells

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

Mechanisms of drug resistance in colon cancer and its therapeutic strategies

Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib.

Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs.

Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

Lapatinib antagonizes multidrug resistance-associated protein 1-mediated multidrug resistance by inhibiting its transport function.

Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome.

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

P304

1097

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.01097

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jing-Quan Wang

P577

2018-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30356705

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

multiple drug resistance

P932

6189370

http://www.w3.org/2001/XMLSchema#string